NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cartography Biosciences

Cartography Biosciences

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://cartography.bio/

Last Round

Strategic

May 6, 2026

Total Funding Raised

$144M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cartography Biosciences is a biotechnology company that develops precision cancer immunotherapies by utilizing multi-omics profiling to construct a comprehensive tumor antigen atlas.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

precision oncologytumor-selective antigensdrug discoveryantigen discoverycancer therapeuticsbiotechtarget validationcomputational biologyAI drug discoveryinvestigational new drugINDtargeted therapypharma collaborationin silico discoverynext-gen cancer medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cartography Biosciences Comparables

Compare Cartography Biosciences with similar companies based on industry and business-model similarity.

Cartography Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enara Bio
84%
Epitopea
82%
Immunai
79%

Cartography Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 6, 2026
Series BOct 2, 2025
StrategicMay 28, 2024
Series AJul 19, 2022
SeedNov 23, 2021

Key People

Founding team and executive leadership

Kevin Parker

Co-Founder, CEO

Founding Team

Cartography Biosciences Investors

Notable investors and investment history

Cartography Biosciences investors
InvestorRounds
Andreessen HorowitzSeries A, Series B, Seed
Finchley Healthcare VenturesSeries B
RM Global PartnersSeries B
Lotte Holdings Healthcare and Biopharmaceutical CVCSeries B
GaingelsSeries A, Series B
ARTIS VenturesSeries A, Series B
Catalio Capital ManagementSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 2, 2025

    $67M round led by Pfizer Ventures

  • Oct 2, 2025

    Michael Baran, Partner at Pfizer Ventures, joins the board.

Cartography Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cartography Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cartography Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range67
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.